-
1
-
-
0032572913
-
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
-
9718377 10.1056/NEJM199808273390903 1:CAS:528:DyaK1cXlvVyrtr8%3D
-
Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584-90.
-
(1998)
N Engl J Med
, vol.339
, pp. 584-590
-
-
Besarab, A.1
Bolton, W.K.2
Browne, J.K.3
Egrie, J.C.4
Nissenson, A.R.5
Okamoto, D.M.6
Schwab, S.J.7
Goodkin, D.A.8
-
2
-
-
33751002326
-
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
-
CREATE Investigators 17108342 10.1056/NEJMoa062276 1:CAS:528: DC%2BD28Xht1Wqt7fM
-
Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, CREATE Investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355:2071-784.
-
(2006)
N Engl J Med
, vol.355
, pp. 2071-2784
-
-
Drueke, T.B.1
Locatelli, F.2
Clyne, N.3
Eckardt, K.U.4
MacDougall, I.C.5
Tsakiris, D.6
Burger, H.U.7
-
3
-
-
33750983605
-
Correction of anemia with epoetin alfa in chronic kidney disease
-
CHOIR Investigators 17108343 10.1056/NEJMoa065485 1:CAS:528: DC%2BD28Xht1Wqt7fN
-
Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085-98.
-
(2006)
N Engl J Med
, vol.355
, pp. 2085-2098
-
-
Singh, A.K.1
Szczech, L.2
Tang, K.L.3
Barnhart, H.4
Sapp, S.5
Wolfson, M.6
-
4
-
-
70949108082
-
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
-
the TREAT Investigators 19880844 10.1056/NEJMoa0907845
-
Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, the TREAT Investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019-32.
-
(2009)
N Engl J Med
, vol.361
, pp. 2019-2032
-
-
Pfeffer, M.A.1
Burdmann, E.A.2
Chen, C.Y.3
Cooper, M.E.4
De Zeeuw, D.5
Eckardt, K.U.6
Feyzi, J.M.7
Ivanovich, P.8
Kewalramani, R.9
Levey, A.S.10
Lewis, E.F.11
McGill, J.B.12
McMurray, J.J.13
Parfrey, P.14
Parving, H.H.15
Remuzzi, G.16
Singh, A.K.17
Solomon, S.D.18
-
5
-
-
75149198323
-
Does TREAT give the boot to ESAs in the treatment of CKD anemia?
-
20035034 10.1681/ASN.2009111127
-
Singh AK. Does TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol. 2010;21:2-6.
-
(2010)
J Am Soc Nephrol
, vol.21
, pp. 2-6
-
-
Singh, A.K.1
-
6
-
-
79955958017
-
Hepcidin and iron regulation, ten years later
-
21346250 10.1182/blood-2011-01-258467 1:CAS:528:DC%2BC3MXlvFKmu7g%3D
-
Ganz T. Hepcidin and iron regulation, ten years later. Blood. 2011;117:4425-33.
-
(2011)
Blood
, vol.117
, pp. 4425-4433
-
-
Ganz, T.1
-
7
-
-
77954249308
-
Two to tango: Regulation of Mammalian iron metabolism
-
20603012 10.1016/j.cell.2010.06.028 1:CAS:528:DC%2BC3cXpt1Cjt7k%3D
-
Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell. 2010;142:24-38.
-
(2010)
Cell
, vol.142
, pp. 24-38
-
-
Hentze, M.W.1
Muckenthaler, M.U.2
Galy, B.3
Camaschella, C.4
-
8
-
-
84864285226
-
Hepcidin: Another culprit for complications in patients with chronic kidney disease?
-
21785039 10.1093/ndt/gfr410 1:CAS:528:DC%2BC3MXhtlGqtr7F
-
Nakanishi T, Hasuike Y, Otaki Y, Kida A, Nonoguchi H, Kuragano T. Hepcidin: another culprit for complications in patients with chronic kidney disease? Nephrol Dial Transplant. 2011;26:3092-100.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 3092-3100
-
-
Nakanishi, T.1
Hasuike, Y.2
Otaki, Y.3
Kida, A.4
Nonoguchi, H.5
Kuragano, T.6
-
9
-
-
0031780146
-
The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - The experience of the Lombardy Dialysis Registry
-
9681705 10.1093/ndt/13.7.1642 1:STN:280:DyaK1czksFSgsg%3D%3D
-
Locatelli F, Conte F, Marcelli D. The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry. Nephrol Dial Transplant. 1998;13:1642-4.
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 1642-1644
-
-
Locatelli, F.1
Conte, F.2
Marcelli, D.3
-
10
-
-
9144264827
-
Anaemia in haemodialysis patients of five European countries: Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
-
14671047 10.1093/ndt/gfg458
-
Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, Greenwood R, Feldman HI, Port FK, Held PJ. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004;19:121-32.
-
(2004)
Nephrol Dial Transplant
, vol.19
, pp. 121-132
-
-
Locatelli, F.1
Pisoni, R.L.2
Combe, C.3
Bommer, J.4
Andreucci, V.E.5
Piera, L.6
Greenwood, R.7
Feldman, H.I.8
Port, F.K.9
Held, P.J.10
-
11
-
-
33645474065
-
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients
-
16565261 10.1681/ASN.2005090997 1:CAS:528:DC%2BD28XjvFSqtrY%3D
-
Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol. 2006;17:1181-91.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 1181-1191
-
-
Regidor, D.L.1
Kopple, J.D.2
Kovesdy, C.P.3
Kilpatrick, R.D.4
McAllister, C.J.5
Aronovitz, J.6
Greenland, S.7
Kalantar-Zadeh, K.8
-
12
-
-
33846669860
-
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: A meta-analysis
-
17276778 10.1016/S0140-6736(07)60194-9 1:CAS:528:DC%2BD2sXht1OrsLY%3D
-
Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet. 2007;369:381-8.
-
(2007)
Lancet
, vol.369
, pp. 381-388
-
-
Phrommintikul, A.1
Haas, S.J.2
Elsik, M.3
Krum, H.4
-
13
-
-
38449094145
-
Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets
-
17942772 10.2215/CJN.02380607 1:CAS:528:DC%2BD2sXhtlGgsbfE
-
Fishbane S, Besarab A. Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets. Clin J Am Soc Nephrol. 2007;2:1274-82.
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, pp. 1274-1282
-
-
Fishbane, S.1
Besarab, A.2
-
14
-
-
83655163838
-
Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: Results from a cohort study from the Dialysis Registry in Japan
-
Fukuma S, Yamaguchi T, Hashimoto S, Nakai S, Iseki K, Tsubakihara Y, Fukuhara S.: Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the Dialysis Registry in Japan. Am J Kidney Dis. 2012 59(1) 108-16.
-
(2012)
Am J Kidney Dis.
, vol.59
, Issue.1
, pp. 108-116
-
-
Fukuma, S.1
Yamaguchi, T.2
Hashimoto, S.3
Nakai, S.4
Iseki, K.5
Tsubakihara, Y.6
Fukuhara, S.7
-
15
-
-
49149113180
-
Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients
-
18417744 10.2215/CJN.04601007 1:CAS:528:DC%2BD1cXovFelu7k%3D
-
Kilpatrick RD, Critchlow CW, Fishbane S, Besarab A, Stehman-Breen C, Krishnan M, Bradbury BD. Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:1077-83.
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 1077-1083
-
-
Kilpatrick, R.D.1
Critchlow, C.W.2
Fishbane, S.3
Besarab, A.4
Stehman-Breen, C.5
Krishnan, M.6
Bradbury, B.D.7
-
16
-
-
77956255701
-
On behalf of the Anaemia Working Group of European Renal Best Practice (ERBP).: Target haemoglobin to aim for with erythropoiesis-stimulating agents: A position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp(R) Therapy (TREAT) Study
-
20591813 10.1093/ndt/gfq336
-
Locatelli F, Aljama P, Canaud B, Covic A, De Francisco A, Macdougall IC, Wiecek A. On behalf of the Anaemia Working Group of European Renal Best Practice (ERBP).: target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp(R) Therapy (TREAT) Study. Nephrol Dial Transplant. 2010;25:2846-50.
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 2846-2850
-
-
Locatelli, F.1
Aljama, P.2
Canaud, B.3
Covic, A.4
De Francisco, A.5
MacDougall, I.C.6
Wiecek, A.7
-
17
-
-
79955024469
-
Iron supplementation to treat anemia in patients with chronic kidney disease
-
20956992 10.1038/nrneph.2010.139 1:CAS:528:DC%2BC3cXhsVyhtbfP
-
Besarab A, Coyne DW. Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol. 2010;6:699-710.
-
(2010)
Nat Rev Nephrol
, vol.6
, pp. 699-710
-
-
Besarab, A.1
Coyne, D.W.2
-
18
-
-
0035168242
-
Hyporesponsiveness to recombinant human erythropoietin
-
11590253 10.1093/ndt/16.suppl-7.25
-
Drüeke T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant. 2001;16:25-8.
-
(2001)
Nephrol Dial Transplant
, vol.16
, pp. 25-28
-
-
Drüeke, T.1
-
19
-
-
0032873161
-
Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit
-
10516375 10.1053/ajkd.1999.v34.aajkd0344b0040 1:CAS:528: DyaK1MXntVCmtb8%3D
-
Macdougall IC, Chandler G, Elston O, Harchowal J. Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit. Am J Kidney Dis. 1999;34:S40-6.
-
(1999)
Am J Kidney Dis
, vol.34
-
-
MacDougall, I.C.1
Chandler, G.2
Elston, O.3
Harchowal, J.4
-
20
-
-
0028535168
-
Monitoring of iron status and iron supplementation in patients treated with erythropoietin
-
7881986 10.1097/00041552-199411000-00010 1:STN:280:DyaK2M7oslOqsA%3D%3D
-
Macdougall IC. Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Opin Nephrol Hypertens. 1994;3:620-5.
-
(1994)
Curr Opin Nephrol Hypertens
, vol.3
, pp. 620-625
-
-
MacDougall, I.C.1
-
21
-
-
0030048578
-
How to diagnose and correct iron deficiency during r-huEPO therapy-a consensus report
-
8671774 10.1093/oxfordjournals.ndt.a027248
-
Hörl WH, Cavill I, MacDougall IC, Schaefer RM, Sunder-Plassmann G. How to diagnose and correct iron deficiency during r-huEPO therapy-a consensus report. Nephrol Dial Transplant. 1996;11:246-50.
-
(1996)
Nephrol Dial Transplant
, vol.11
, pp. 246-250
-
-
Hörl, W.H.1
Cavill, I.2
MacDougall, I.C.3
Schaefer, R.M.4
Sunder-Plassmann, G.5
-
22
-
-
33846694048
-
Clinical aspects of iron use in the anemia of kidney disease
-
17229908 10.1681/ASN.2006080856
-
Horl WH. Clinical aspects of iron use in the anemia of kidney disease. J Am Soc Nephrol. 2007;18:382-93.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 382-393
-
-
Horl, W.H.1
-
23
-
-
0345099328
-
Intravenous iron as adjuvant therapy: A two-edged sword?
-
10.1093/ndt/gfg1088
-
Cavill I. Intravenous iron as adjuvant therapy: a two-edged sword? Nephrol Dial Transplant. 2003;18:24-8.
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 24-28
-
-
Cavill, I.1
-
24
-
-
0023120533
-
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase i and II clinical trial
-
3537801 10.1056/NEJM198701083160203 1:STN:280:DyaL2s%2FmsFSjsw%3D%3D
-
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med. 1987;316:73-8.
-
(1987)
N Engl J Med
, vol.316
, pp. 73-78
-
-
Eschbach, J.W.1
Egrie, J.C.2
Downing, M.R.3
Browne, J.K.4
Adamson, J.W.5
-
25
-
-
0024970849
-
Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously
-
2504356 10.1136/bmj.299.6692.157 1:STN:280:DyaL1MzltlSntg%3D%3D
-
Macdougall IC, Hutton RD, Cavill I, Coles GA, Williams JD. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. BMJ. 1989;299:157-8.
-
(1989)
BMJ
, vol.299
, pp. 157-158
-
-
MacDougall, I.C.1
Hutton, R.D.2
Cavill, I.3
Coles, G.A.4
Williams, J.D.5
-
26
-
-
9644295720
-
Safety of intravenous iron in clinical practice: Implications for anemia management protocols
-
Aronoff GR. Safety of intravenous iron in clinical practice: implications for anemia management protocols. J Am Soc Nephrol. 2004;2:99-106.
-
(2004)
J Am Soc Nephrol
, vol.2
, pp. 99-106
-
-
Aronoff, G.R.1
-
27
-
-
33947212276
-
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study
-
10.1681/ASN.2006091034
-
Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol. 2007;18:97594.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 97594
-
-
Coyne, D.W.1
Kapoian, T.2
Suki, W.3
Singh, A.K.4
Moran, J.E.5
Dahl, N.V.6
Rizkala, A.R.7
-
28
-
-
0037335627
-
59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography
-
12614222 10.1046/j.1365-2141.2003.03590.x 1:CAS:528:DC%2BD3sXjtVeqs74%3D
-
59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography. Br J Haematol. 2003;120:853-9.
-
(2003)
Br J Haematol
, vol.120
, pp. 853-859
-
-
Beshara, S.1
Sorensen, J.2
Lubberink, M.3
Tolmachev, V.4
Langstrom, B.5
Antoni, G.6
Danielson, B.G.7
Lundqvist, H.8
-
29
-
-
0032934971
-
Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: A study using positron emission tomography
-
10050711 10.1046/j.1365-2141.1999.01179.x 1:CAS:528:DyaK1MXhsV2gsbY%3D
-
Beshara S, Lundqvist H, Sundin J, Lubberink M, Tolmachev V, Valind S, Antoni G, Langstrom B, Danielson BG. Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography. Br J Haematol. 1999;104:296-302.
-
(1999)
Br J Haematol
, vol.104
, pp. 296-302
-
-
Beshara, S.1
Lundqvist, H.2
Sundin, J.3
Lubberink, M.4
Tolmachev, V.5
Valind, S.6
Antoni, G.7
Langstrom, B.8
Danielson, B.G.9
-
30
-
-
77949726600
-
Ferrokinetics in normal persons and in patients having various erythropoietic disorders
-
14897912 10.1172/JCI102562
-
Huff RL, Elmlinger PJ, Garcia JF, Oda JM, Cockrell MC, Lawrence JH. Ferrokinetics in normal persons and in patients having various erythropoietic disorders. J Clin Invest. 1951;30:1512-26.
-
(1951)
J Clin Invest
, vol.30
, pp. 1512-1526
-
-
Huff, R.L.1
Elmlinger, P.J.2
Garcia, J.F.3
Oda, J.M.4
Cockrell, M.C.5
Lawrence, J.H.6
-
31
-
-
0030854921
-
Utilization of intracellular ferritin iron for hemoglobin synthesis in developing human erythroid precursors
-
9226184 1:CAS:528:DyaK2sXksF2jtLw%3D
-
Vaisman B, Fibach E, Konijn AM. Utilization of intracellular ferritin iron for hemoglobin synthesis in developing human erythroid precursors. Blood. 1997;90:831-8.
-
(1997)
Blood
, vol.90
, pp. 831-838
-
-
Vaisman, B.1
Fibach, E.2
Konijn, A.M.3
-
32
-
-
0031028178
-
Tissue-specific regulation of iron metabolism and heme synthesis: Distinct control mechanisms in erythroid cells
-
8978272 1:CAS:528:DyaK2sXhsFahuw%3D%3D
-
Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood. 1997;89:1-25.
-
(1997)
Blood
, vol.89
, pp. 1-25
-
-
Ponka, P.1
-
33
-
-
40349103525
-
Macrophages function as a ferritin iron source for cultured human erythroid precursors
-
17902167 10.1002/jcb.21499 1:CAS:528:DC%2BD1cXjtVyntb0%3D
-
Leimberg MJ, Prus E, Konijn AM, Fibach E. Macrophages function as a ferritin iron source for cultured human erythroid precursors. J Cell Biochem. 2008;103:1211-8.
-
(2008)
J Cell Biochem
, vol.103
, pp. 1211-1218
-
-
Leimberg, M.J.1
Prus, E.2
Konijn, A.M.3
Fibach, E.4
-
34
-
-
81255135833
-
Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia
-
22019886 10.1038/nm.2462 1:CAS:528:DC%2BC3MXhtlGks7rN
-
Coulon S, Dussiot M, Grapton D, Maciel TT, Wang PH, Callens C, Tiwari MK, Agarwal S, Fricot A, Vandekerckhove J, Tamouza H, Zermati Y, Ribeil JA, Djedaini K, Oruc Z, Pascal V, Courtois G, Arnulf B, Alyanakian MA, Mayeux P, Leanderson T, Benhamou M, Cogné M, Monteiro RC, Hermine O, Moura IC. Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia. Nat Med. 2011;17:1456-65.
-
(2011)
Nat Med
, vol.17
, pp. 1456-1465
-
-
Coulon, S.1
Dussiot, M.2
Grapton, D.3
MacIel, T.T.4
Wang, P.H.5
Callens, C.6
Tiwari, M.K.7
Agarwal, S.8
Fricot, A.9
Vandekerckhove, J.10
Tamouza, H.11
Zermati, Y.12
Ribeil, J.A.13
Djedaini, K.14
Oruc, Z.15
Pascal, V.16
Courtois, G.17
Arnulf, B.18
Alyanakian, M.A.19
Mayeux, P.20
Leanderson, T.21
Benhamou, M.22
Cogné, M.23
Monteiro, R.C.24
Hermine, O.25
Moura, I.C.26
more..
-
35
-
-
14744278436
-
Anemia of chronic disease
-
15758012 10.1056/NEJMra041809 1:CAS:528:DC%2BD2MXit1Wkt7Y%3D
-
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011-23.
-
(2005)
N Engl J Med
, vol.352
, pp. 1011-1023
-
-
Weiss, G.1
Goodnough, L.T.2
-
36
-
-
0036232280
-
Anemia management in chronic kidney disease: Role of factors affecting epoetin responsiveness
-
11961032 10.1097/01.ASN.0000016440.52271.F7
-
Eschbach JW. Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness. J Am Soc Nephrol. 2002;13:1412-4.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 1412-1414
-
-
Eschbach, J.W.1
-
37
-
-
2542454908
-
Defective regulation of iron transporters leading to iron excess in the polymorphonuclear leukocytes of patients on maintenance hemodialysis
-
15168383 10.1053/j.ajkd.2004.02.016 1:CAS:528:DC%2BD2cXltlGjs7w%3D
-
Otaki Y, Nakanishi T, Hasuike Y, Moriguchi R, Nanami M, Hama Y, Izumi M, Takamitsu Y. Defective regulation of iron transporters leading to iron excess in the polymorphonuclear leukocytes of patients on maintenance hemodialysis. Am J Kidney Dis. 2004;43:1030-9.
-
(2004)
Am J Kidney Dis
, vol.43
, pp. 1030-1039
-
-
Otaki, Y.1
Nakanishi, T.2
Hasuike, Y.3
Moriguchi, R.4
Nanami, M.5
Hama, Y.6
Izumi, M.7
Takamitsu, Y.8
-
38
-
-
68749109770
-
Interleukin-6 is a predictor of mortality in stable hemodialysis patients
-
19690405 10.1159/000235687 1:CAS:528:DC%2BD1MXht1Wms77J
-
Hasuike Y, Nonoguchi H, Ito K, Naka M, Kitamura R, Nanami M, Tokuyama M, Kida A, Otaki Y, Kuragano T, Nakanishi T. Interleukin-6 is a predictor of mortality in stable hemodialysis patients. Am J Nephrol. 2009;30:389-98.
-
(2009)
Am J Nephrol
, vol.30
, pp. 389-398
-
-
Hasuike, Y.1
Nonoguchi, H.2
Ito, K.3
Naka, M.4
Kitamura, R.5
Nanami, M.6
Tokuyama, M.7
Kida, A.8
Otaki, Y.9
Kuragano, T.10
Nakanishi, T.11
-
39
-
-
0037926880
-
Cytokine-mediated regulation of iron transport in human monocytic cells
-
12522003 10.1182/blood-2002-08-2459 1:CAS:528:DC%2BD3sXktVGmsro%3D
-
Ludwiczek S, Aigner E, Theurl I, Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood. 2003;101:4148-54.
-
(2003)
Blood
, vol.101
, pp. 4148-4154
-
-
Ludwiczek, S.1
Aigner, E.2
Theurl, I.3
Weiss, G.4
-
40
-
-
33644798028
-
Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells
-
16224057 10.1161/01.ATV.0000190610.63878.20 1:CAS:528:DC%2BD2MXht1Crt73L
-
Nanami M, Ookawara T, Otaki Y, Ito K, Moriguchi R, Miyagawa K, Hasuike Y, Izumi M, Eguchi H, Suzuki K, Nakanishi T. Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells. Arterioscler Thromb Vasc Biol. 2005;25:2495-501.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 2495-2501
-
-
Nanami, M.1
Ookawara, T.2
Otaki, Y.3
Ito, K.4
Moriguchi, R.5
Miyagawa, K.6
Hasuike, Y.7
Izumi, M.8
Eguchi, H.9
Suzuki, K.10
Nakanishi, T.11
-
41
-
-
0035902605
-
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice
-
11447267 10.1073/pnas.151179498 1:CAS:528:DC%2BD3MXls1Witbs%3D
-
Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA. 2001;98:8780-5.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 8780-8785
-
-
Nicolas, G.1
Bennoun, M.2
Devaux, I.3
Beaumont, C.4
Grandchamp, B.5
Kahn, A.6
Vaulont, S.7
-
42
-
-
0035896581
-
A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload
-
11113132 10.1074/jbc.M008923200 1:CAS:528:DC%2BD3MXitFKhtbs%3D
-
Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811-9.
-
(2001)
J Biol Chem
, vol.276
, pp. 7811-7819
-
-
Pigeon, C.1
Ilyin, G.2
Courselaud, B.3
Leroyer, P.4
Turlin, B.5
Brissot, P.6
Loreal, O.7
-
43
-
-
10844258104
-
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
-
15514116 10.1126/science.1104742 1:CAS:528:DC%2BD2cXhtVOjsL3K
-
Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-3.
-
(2004)
Science
, vol.306
, pp. 2090-2093
-
-
Nemeth, E.1
Tuttle, M.S.2
Powelson, J.3
Vaughn, M.B.4
Donovan, A.5
Ward, D.M.6
Ganz, T.7
Kaplan, J.8
-
44
-
-
79953223315
-
Intestinal DMT1 cotransporter is downregulated by hepcidin via proteasome-internalization and degradation
-
21199652 10.1053/j.gastro.2010.12.037 1:CAS:528:DC%2BC3MXjvVOkt74%3D
-
Brasse-Lagnel C, Karim Z, Letteron P, Bekri S, Bado A, Beaumont C. Intestinal DMT1 cotransporter is downregulated by hepcidin via proteasome-internalization and degradation. Gastroenterology. 2011;140:1261-71.
-
(2011)
Gastroenterology
, vol.140
, pp. 1261-1271
-
-
Brasse-Lagnel, C.1
Karim, Z.2
Letteron, P.3
Bekri, S.4
Bado, A.5
Beaumont, C.6
-
45
-
-
77952313581
-
Determinants of hepcidin in patients on maintenance hemodialysis: Role of inflammation
-
20484891 10.1159/000312381 1:CAS:528:DC%2BC3cXnvFWiu7c%3D
-
Kuragano T, Shimonaka Y, Kida A, Furuta M, Nanami M, Otaki Y, Hasuike Y, Nonoguchi H, Nakanishi T. Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation. Am J Nephrol. 2010;31:534-40.
-
(2010)
Am J Nephrol
, vol.31
, pp. 534-540
-
-
Kuragano, T.1
Shimonaka, Y.2
Kida, A.3
Furuta, M.4
Nanami, M.5
Otaki, Y.6
Hasuike, Y.7
Nonoguchi, H.8
Nakanishi, T.9
-
46
-
-
70349245261
-
Serum hepcidin concentration in chronic haemodialysis patients: Associations and effects of dialysis, iron and erythropoietin therapy
-
19563467 10.1111/j.1365-2362.2009.02182.x 1:CAS:528:DC%2BD1MXhtlWhsrvI
-
Weiss G, Theurl I, Eder S, Koppelstaetter C, Kurz K, Sonnweber T, Kobold U, Mayer G. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Eur J Clin Invest. 2009;39:883-90.
-
(2009)
Eur J Clin Invest
, vol.39
, pp. 883-890
-
-
Weiss, G.1
Theurl, I.2
Eder, S.3
Koppelstaetter, C.4
Kurz, K.5
Sonnweber, T.6
Kobold, U.7
Mayer, G.8
-
47
-
-
77957588960
-
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients
-
20668427 10.1038/ki.2010.254 1:CAS:528:DC%2BC3cXht1WmtLnO
-
Ford BA, Eby CS, Scott MG, Coyne DW. Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients. Kidney Int. 2010;78:769-73.
-
(2010)
Kidney Int
, vol.78
, pp. 769-773
-
-
Ford, B.A.1
Eby, C.S.2
Scott, M.G.3
Coyne, D.W.4
-
48
-
-
2342510407
-
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
-
15124018 1:CAS:528:DC%2BD2cXjvVOqsrY%3D
-
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-6.
-
(2004)
J Clin Invest
, vol.113
, pp. 1271-1276
-
-
Nemeth, E.1
Rivera, S.2
Gabayan, V.3
Keller, C.4
Taudorf, S.5
Pedersen, B.K.6
Ganz, T.7
-
49
-
-
77957166516
-
Importance of ferritin for optimizing anemia therapy in chronic kidney disease
-
20881381 10.1159/000320733 1:CAS:528:DC%2BC3cXhsVekt7zN
-
Nakanishi T, Kuragano T, Nanami M, Otaki Y, Nonoguchi H, Hasuike Y. Importance of ferritin for optimizing anemia therapy in chronic kidney disease. Am J Nephrol. 2010;32:439-46.
-
(2010)
Am J Nephrol
, vol.32
, pp. 439-446
-
-
Nakanishi, T.1
Kuragano, T.2
Nanami, M.3
Otaki, Y.4
Nonoguchi, H.5
Hasuike, Y.6
-
50
-
-
67149084949
-
Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: Diagnostic and therapeutic implications
-
19293425 10.1182/blood-2008-12-195651 1:CAS:528:DC%2BD1MXmslalu7k%3D
-
Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009;113:5277-86.
-
(2009)
Blood
, vol.113
, pp. 5277-5286
-
-
Theurl, I.1
Aigner, E.2
Theurl, M.3
Nairz, M.4
Seifert, M.5
Schroll, A.6
Sonnweber, T.7
Eberwein, L.8
Witcher, D.R.9
Murphy, A.T.10
Wroblewski, V.J.11
Wurz, E.12
Datz, C.13
Weiss, G.14
-
51
-
-
74049143534
-
Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia
-
19863534 10.1111/j.1365-2141.2009.07961.x
-
Theurl I, Finkenstedt A, Schroll A, Nairz M, Sonnweber T, Bellmann-Weiler R, Theurl M, Seifert M, Wroblewski VJ, Murphy AT, Witcher D, Zoller H, Weiss G. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia. Br J Haematol. 2010;148:449-55.
-
(2010)
Br J Haematol
, vol.148
, pp. 449-455
-
-
Theurl, I.1
Finkenstedt, A.2
Schroll, A.3
Nairz, M.4
Sonnweber, T.5
Bellmann-Weiler, R.6
Theurl, M.7
Seifert, M.8
Wroblewski, V.J.9
Murphy, A.T.10
Witcher, D.11
Zoller, H.12
Weiss, G.13
-
52
-
-
73449108729
-
Iron absorption and distribution in TNF(DeltaARE/+) mice, a model of chronic inflammation
-
10.1016/j.jtemb.2009.10.002
-
Schümann K, Herbach N, Kerling C, Seifert M, Fillebeen C, Prysch I, Reich J, Weiss G, Pantopoulos K. Iron absorption and distribution in TNF(DeltaARE/+) mice, a model of chronic inflammation. J Trace Elem Med Biol. 2010;24:59-66.
-
(2010)
J Trace Elem Med Biol
, vol.24
, pp. 59-66
-
-
Schümann, K.1
Herbach, N.2
Kerling, C.3
Seifert, M.4
Fillebeen, C.5
Prysch, I.6
Reich, J.7
Weiss, G.8
Pantopoulos, K.9
-
53
-
-
78649520453
-
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents
-
Tessitore N, Girelli D, Campostrini N, Bedogna V, Pietro Solero G, Castagna A, Melilli E, Mantovani W, De Matteis G, Olivieri O, Poli A, Lupo A. Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrol Dial Transplant. 2010;25:3996-4002.
-
(2010)
Nephrol Dial Transplant.
, vol.25
, pp. 3996-4002
-
-
Tessitore, N.1
Girelli, D.2
Campostrini, N.3
Bedogna, V.4
Pietro Solero, G.5
Castagna, A.6
Melilli, E.7
Mantovani, W.8
De Matteis, G.9
Olivieri, O.10
Poli, A.11
Lupo, A.12
-
54
-
-
0024446959
-
Food iron absorption in idiopathic hemochromatosis
-
2804357 1:STN:280:DyaK3c%2FivVOmsA%3D%3D
-
Lynch SR, Skikne BS, Cook JD. Food iron absorption in idiopathic hemochromatosis. Blood. 1989;74:2187-93.
-
(1989)
Blood
, vol.74
, pp. 2187-2193
-
-
Lynch, S.R.1
Skikne, B.S.2
Cook, J.D.3
-
56
-
-
0016138423
-
Serum ferritin as a measure of iron stores in normal subjects
-
4472911 1:CAS:528:DyaE2cXkvFShsrk%3D
-
Cook JD, Lipschitz DA, Miles LE, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr. 1974;27:681-7.
-
(1974)
Am J Clin Nutr
, vol.27
, pp. 681-687
-
-
Cook, J.D.1
Lipschitz, D.A.2
Miles, L.E.3
Finch, C.A.4
-
57
-
-
63649105326
-
Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men
-
19211819 10.3945/ajcn.2008.27297 1:CAS:528:DC%2BD1MXjslSks7g%3D
-
Roe MA, Collings R, Dainty JR, Swinkels DW, Fairweather-Tait SJ. Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr. 2009;89:1088-91.
-
(2009)
Am J Clin Nutr
, vol.89
, pp. 1088-1091
-
-
Roe, M.A.1
Collings, R.2
Dainty, J.R.3
Swinkels, D.W.4
Fairweather-Tait, S.J.5
-
58
-
-
0024348472
-
Model of reticuloendothelial iron metabolism in humans: Abnormal behavior in idiopathic hemochromatosis and in inflammation
-
2502204 1:CAS:528:DyaL1MXlslWltLg%3D
-
Fillet G, Beguin Y, Baldelli L. Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood. 1989;74:844-51.
-
(1989)
Blood
, vol.74
, pp. 844-851
-
-
Fillet, G.1
Beguin, Y.2
Baldelli, L.3
-
59
-
-
84857617139
-
Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children
-
Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE, Drakesmith H. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood. 2012 119(8) 1922-8.
-
(2012)
Blood
, vol.119
, Issue.8
, pp. 1922-1928
-
-
Prentice, A.M.1
Doherty, C.P.2
Abrams, S.A.3
Cox, S.E.4
Atkinson, S.H.5
Verhoef, H.6
Armitage, A.E.7
Drakesmith, H.8
-
60
-
-
84863070053
-
Is hepcidin-25 a clinically relevant parameter for the iron status in hemodialysis patients?
-
20797577 10.1053/j.jrn.2010.06.006
-
Brǎtescu LO, Bârsan L, Munteanu D, Stancu S, Mircescu G. Is hepcidin-25 a clinically relevant parameter for the iron status in hemodialysis patients? J Ren Nutr. 2010;20:S77-83.
-
(2010)
J Ren Nutr
, vol.20
-
-
Brǎtescu, L.O.1
Bârsan, L.2
Munteanu, D.3
Stancu, S.4
Mircescu, G.5
-
61
-
-
78651386209
-
Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin
-
20962740 10.1038/ki.2010.382 1:CAS:528:DC%2BC3MXlsFKrtA%3D%3D
-
Hasegawa T, Bragg-Gresham JL, Pisoni RL, Robinson BM, Fukuhara S, Akiba T, Saito A, Kurokawa K, Akizawa T. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. Kidney Int. 2011;79:340-6.
-
(2011)
Kidney Int
, vol.79
, pp. 340-346
-
-
Hasegawa, T.1
Bragg-Gresham, J.L.2
Pisoni, R.L.3
Robinson, B.M.4
Fukuhara, S.5
Akiba, T.6
Saito, A.7
Kurokawa, K.8
Akizawa, T.9
-
62
-
-
13844254456
-
Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients
-
Japanese Society for Dialysis Therapy 10.1111/j.1774-9987.2004.00199.x
-
Gejyo F, Saito A, Akizawa T, Akiba T, Sakai T, Suzuki M, Nishi S, Tsubakihara Y, Hirakata H, Bessho M, Japanese Society for Dialysis Therapy. Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients. Ther Apher Dial. 2004;2004(8):443-59.
-
(2004)
Ther Apher Dial
, vol.2004
, Issue.8
, pp. 443-459
-
-
Gejyo, F.1
Saito, A.2
Akizawa, T.3
Akiba, T.4
Sakai, T.5
Suzuki, M.6
Nishi, S.7
Tsubakihara, Y.8
Hirakata, H.9
Bessho, M.10
|